| cpd01232 | 851456-28-5 | tetrapeptide | RLNF | L-Arginyl-L-arginyl-N-[3-(phenylmethoxy)phenyl]-L-leucinamide | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI |
cpd01233 | 851456-27-4 | tetrapeptide | RLNF | 2-[(6-Chloro-2-phenyl-1H-benzimidazol-1-yl)oxy]acetic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01234 | 851456-26-3 | tetrapeptide | RLNF | 3-Nitro-4-(1H-1,2,4-triazol-1-yl)benzoic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01235 | 851456-25-2 | tetrapeptide | RLNF | 5-Methyl-1-(4-nitrophenyl)-1H-1,2,4-triazole-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01236 | 851456-24-1 | tetrapeptide | RLNF | 1-(4-Fluorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01237 | 851456-23-0 | tetrapeptide | RLNF | 4-(2-Thioxo-1-imidazolidinyl)benzoic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01238 | 851456-22-9 | tetrapeptide | RLNF | 1-(2,4-Dichlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01239 | 851456-21-8 | tetrapeptide | RLNF | 1-(4-Chlorophenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01240 | 851456-20-7 | tetrapeptide | RLNF | 1-(2,4-Dichloro-5-methoxyphenyl)-5-methyl-1H-1,2,4-triazole-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01241 | 851456-19-4 | tetrapeptide | RLNF | 5-Chloro-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid | Anticancer therapy, DNA replication | amide | Andrews, Martin J.et.al (2006)
DOI | cpd01242 | 917877-33-9 | | GRRRQRRKKRGGC | 5′-O-Phosphonoadenylyl-(2′→5′)-adenylyl-(2′→5′)-adenosine | Antimicrobial, antiviral (HIV) | sulfide | Zhou, Longhu;et.al (2006)
DOI | cpd01243 | 917877-32-8 | | CGGRKKRRQRRR | 5′-O-Phosphonoadenylyl-(2′→5′)-adenylyl-(2′→5′)-adenosine | Antimicrobial, antiviral (HIV) | sulfide | Zhou, Longhu;et.al (2006)
DOI | cpd01244 | 917877-31-7 | | CGGRKKRRQRRR | Adenosine monophosphate | Antimicrobial, antiviral (HIV) | sulfide | Zhou, Longhu;et.al (2006)
DOI | cpd01245 | 917877-25-9 | | GGRRKKRRQRRR | 2-Morpholinemethanol, 6-(6-amino-9H-purin-9-yl)-4-(3-azidopropyl)-, 2-phosphinephosphate, (2S,6R)- | Antimicrobial, antiviral (HIV) | triazole | Zhou, Longhu;et.al (2006)
DOI | cpd01246 | 916443-81-7 | | GKRKKKGKLGKKRPRSRC | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01247 | 916443-78-2 | | SRRARRSPRHLGSGC | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01248 | 916443-75-9 | | CVKRGLKLRHVRPRVTRMDV | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01249 | 916443-72-6 | | GKRKKKGKLGKKRPRSRC | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01250 | 916443-68-0 | | SRRARRSPRHLGSGC | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01251 | 916443-64-6 | | SRRARRSPRHLGSGC | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01252 | 916443-62-4 | | CVKRGLKLRHVRPRVTRMDV | Doxorubicin | Antitumor therapy, colon and breast tumors | sulfide | Meyer-et.al (2006)
DOI | cpd01253 | 910293-38-8 | | XRGDF | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01254 | 910293-37-7 | | XRGDS | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01255 | 910293-36-6 | | XRGDS | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01256 | 910117-30-5 | | XXGDF | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01257 | 910117-28-1 | | XXGDV | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01258 | 910117-26-9 | | XXGDS | 2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-1-(4-hydroxy-3,5-dimethoxyphenyl)-, 2-(1,1-dimethylethyl) ester, (3S)- | Antithrombotic | amide | Bi, Wei;et.al (2006)
DOI | cpd01259 | 910117-33-8 | alanyl-oligovaline | AVVVVVV | Phorphirine derivative | Diagnosis, CD spectoscopy | amide | Guryanov, Ivan;et.al (2006)
DOI | cpd01260 | 910117-27-0 | alanyl-oligovaline | AVVVVV | Phorphirine derivative | Diagnosis, CD spectoscopy | amide | Guryanov, Ivan;et.al (2006)
DOI | cpd01261 | 910117-22-5 | alanyl-oligovaline | AVVV | Phorphirine derivative | Diagnosis, CD spectoscopy | amide | Guryanov, Ivan;et.al (2006)
DOI | 
